|
| |
| | 66792 | | 01.10.2019 | | Sanofi-Aventis (Suisse) SA | | | | | | | | | | | | 06.03. | | | | 06.03. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | Cablivi 10mg | poudre et solvent pour solution injectable | poudre et solvent pour solution injectable (Caplacizumabum 10 mg) | B01AX07 | CI |
|
|
|